George Tidmarsh, head of the Food and Drug Administration’s (FDA) drug center, resigned Sunday following allegations that he misused his regulatory power to financially harm a former business associate.
STAT News, in its report, said FDA Commissioner Marty Makary placed Tidmarsh on administrative leave after opening an investigation into his conduct in recent days based on a complaint filed against Tidmarsh by Kevin Tang, a San Diego-based health care investor and business owner.
